By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Two woman in Ripollet, Catalonia wearing face masks outside a coronavirus testing area.PAU BARRENA/AFP via Getty Images Latest coronavirus news as of 5 pm on 12 August Germany and Spain among a growing list of western…
The race to develop an effective vaccine against the novel coronavirus gathered pace this week, as clinical trials on humans were approved in Germany and launched in the UK. Though there are now around 150 development projects worldwide, the German and British plans are among only five clinical trials on humans which have been approved…
Gain a global perspective on the US and go beyond with curated news and analysis from 600 journalists in 50+ countries covering politics, business, innovation, trends and more. Choose your subscription Not sure which package to choose?Try full access for 4 weeks For 4 weeks receive unlimited Premium digital access to the FT's trusted, award-winning…
April 22, 2020 | 7:45am | Updated April 22, 2020 | 10:37am Germany and the United Kingdom are forging ahead with plans for clinical trials using human volunteers in the race for a vaccine against COVID-19, according to reports. The Paul Ehrlich Institute in Germany on Wednesday green-lighted the trials for a vaccine developed by…
3 min read Over the past few years, a number of celebrities have publicly come out as pansexual,including Wayne Brady, Miley Cyrus, Panic! At The Disco frontman Brendan Urie, model and actress Cara Delevingne, pop star Kesha, and perhaps most famously singer Janelle Monáe, who eschewed all sexual labels in favor of describing herself as
TOPLINE: A Danish study found that replacing the conventional fluorine-18 sodium fluoride (18F-NaF) PET/CT ("NaF" scan for short) with fluorine-18 prostate-specific membrane antigen-1007 (18F-PSMA) PET/CT ("PSMA" scan for short) for the staging of high-risk prostate cancer resulted in significant metastatic stage migration and the alteration of treatment plans in a significant number of patients, thereby
Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : 96404507-7f3b-4a0f-9776-5c3e71d8